Security Snapshot

First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) Institutional Ownership

CUSIP: 33733E203

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

301

Shares (Excl. Options)

8,164,918

Price

$200.82

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
Symbol
FBT
Shares outstanding
11,300,576
Price per share
$200.65
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
8,164,918
Total reported value
$1,639,964,158
% of total 13F portfolios
0%
Share change
+4,733,713
Value change
+$950,260,386
Number of holders
301
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund is tracked under CUSIP 33733E203.
  • 301 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 278 to 301 between Q4 2025 and Q1 2026.
  • Reported value moved from $711,622,833 to $1,639,964,158.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 301 institutions filings for Q1 2026.

Open SEC Evidence

Security key

33733E203

Latest holder period

Q1 2026

13F holders

301

13D/G owners

1

CIK / CUSIP context first

Open Q1 2026 holders FBT full holder history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FIRST TRUST PORTFOLIOS LP 32% $754,049,493 3,651,216 First Trust Portfolios L.P. 31 Jan 2026

As of 31 Mar 2026, 301 institutional investors reported holding 8,164,918 shares of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT). This represents 72% of the company’s total 11,300,576 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) together control 60% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FIRST TRUST ADVISORS LP 31% 3,515,093 +49661% 0.5% $705,899,999
MORGAN STANLEY 4.7% 534,200 +33% 0.01% $107,278,181
WELLS FARGO & COMPANY/MN 3.8% 426,213 +126% 0.02% $85,592,121
LPL Financial LLC 2.6% 295,687 +13% 0.02% $59,379,791
UBS Group AG 1.8% 205,366 +9.8% 0.01% $41,241,600
RAYMOND JAMES FINANCIAL INC 1.8% 202,877 +39% 0.01% $40,741,826
BANK OF AMERICA CORP /DE/ 1.8% 200,959 +5.7% 0% $40,356,665
ROYAL BANK OF CANADA 1.8% 199,981 +29% 0.01% $40,160,000
ENVESTNET ASSET MANAGEMENT INC 1.1% 126,996 +11% 0.01% $25,503,363
Berger Financial Group, Inc 0.92% 104,402 -9.2% 1.2% $20,966,008
Nilsine Partners, LLC 0.84% 95,083 +1715% 1.5% $19,388,375
&PARTNERS 0.69% 78,413 +1119% 0.08% $15,746,887
360 Financial, Inc. 0.69% 78,213 +8.5% 4.7% $15,706,735
Advisory Services Network, LLC 0.67% 75,428 0.2% $15,147,500
WCG Wealth Advisors LLC 0.66% 74,342 0.42% $14,929,286
AMERIPRISE FINANCIAL INC 0.61% 69,393 +52% 0% $13,927,558
STIFEL FINANCIAL CORP 0.61% 68,981 +14% 0.01% $13,853,094
Cetera Investment Advisers 0.59% 66,297 +5.5% 0.01% $13,313,679
Janney Montgomery Scott LLC 0.58% 65,265 -6.8% 0.03% $13,107,000
BENJAMIN EDWARDS INC 0.52% 58,201 +91% 0.12% $11,694,711
ASSETMARK, INC 0.49% 55,217 +19% 0.02% $11,088,678
TRUIST FINANCIAL CORP 0.48% 54,147 -2% 0.01% $10,873,894
D.A. DAVIDSON & CO. 0.47% 53,019 +6.5% 0.06% $10,647,378
OSAIC HOLDINGS, INC. 0.47% 52,725 -0.31% 0.02% $10,590,647
Cambridge Investment Research Advisors, Inc. 0.46% 52,054 +36% 0.03% $10,454,000

Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 8,164,918 $1,639,964,158 +$950,260,386 $200.82 301
2025 Q4 3,444,827 $711,622,833 +$83,120,046 $206.52 278
2025 Q3 3,042,011 $545,834,448 -$11,896,976 $179.29 252
2025 Q2 3,155,408 $509,245,856 -$41,077,763 $161.33 247
2025 Q1 3,418,328 $576,824,224 +$1,866,805 $170.12 266
2024 Q4 3,418,857 $568,580,158 +$41,645,148 $166.21 253
2024 Q3 3,143,605 $540,228,542 -$50,274,497 $171.93 252
2024 Q2 3,468,418 $534,289,452 +$6,575,921 $153.99 247
2024 Q1 3,399,038 $522,621,545 -$94,532,990 $153.77 240
2023 Q4 4,017,594 $634,837,157 -$30,986,867 $158.06 254
2023 Q3 4,190,296 $613,262,596 -$62,820,801 $146.35 239
2023 Q2 4,617,487 $707,129,055 -$19,966,454 $153.14 247
2023 Q1 4,700,385 $728,635,260 -$18,428,171 $155.03 241
2022 Q4 4,877,768 $751,529,554 +$55,433,739 $154.13 239
2022 Q3 4,496,690 $593,813,874 +$22,209,350 $131.98 212
2022 Q2 4,332,609 $587,753,929 -$18,206,139 $135.56 218
2022 Q1 4,448,675 $663,407,924 -$82,106,064 $149.14 212
2021 Q4 4,955,742 $802,113,791 -$46,741,875 $161.96 239
2021 Q3 5,178,909 $859,978,174 -$14,178,042 $166.06 230
2021 Q2 5,220,166 $900,985,426 -$80,585,265 $172.62 227
2021 Q1 5,725,862 $919,195,735 -$21,822,779 $160.50 232
2020 Q4 5,809,688 $976,622,166 -$78,183,499 $167.99 232
2020 Q3 6,096,208 $959,021,765 -$32,144,151 $157.26 210
2020 Q2 6,226,658 $1,045,067,619 +$191,623,157 $167.77 222
2020 Q1 5,157,697 $676,659,157 -$47,084,204 $131.12 193
2019 Q4 5,487,562 $816,287,431 -$74,667,369 $148.72 207
2019 Q3 5,992,894 $742,538,774 -$882,858,217 $123.76 184
2019 Q2 12,569,930 $1,770,181,894 +$35,822,419 $140.84 217
2019 Q1 12,360,195 $1,864,503,721 +$128,595,965 $150.85 224
2018 Q4 11,657,169 $1,449,690,480 -$403,797,433 $124.20 190
2018 Q3 14,181,041 $2,246,741,087 +$1,432,250,063 $158.49 187
2018 Q2 5,133,431 $718,724,343 +$63,854,991 $140.01 154
2018 Q1 4,683,224 $622,474,212 +$91,611,191 $132.90 152
2017 Q4 3,984,755 $496,314,617 +$44,748,999 $124.57 126
2017 Q3 3,605,567 $446,754,001 +$14,480,513 $123.93 115
2017 Q2 3,492,182 $398,275,105 +$56,018,406 $114.04 112
2017 Q1 3,018,492 $316,695,674 -$4,736,324 $105.30 113
2016 Q4 3,095,489 $281,588,359 +$13,238,858 $90.87 107
2016 Q3 2,930,364 $291,496,084 -$4,711,885 $99.71 110
2016 Q2 3,076,251 $274,668,626 -$39,232,497 $89.43 105
2016 Q1 3,349,153 $294,129,961 -$1,892,206,413 $87.56 102
2015 Q4 21,779,226 $2,459,415,016 +$164,656,445 $113.02 127
2015 Q3 20,090,644 $2,036,625,833 +$162,029,493 $101.32 126
2015 Q2 18,456,703 $2,288,765,259 +$285,028,551 $124.02 123
2015 Q1 16,117,838 $1,905,196,132 +$443,224,811 $118.23 119
2014 Q4 12,339,312 $1,258,885,285 +$245,972,458 $102.02 109
2014 Q3 9,633,125 $883,813,866 +$85,577,040 $91.78 95
2014 Q2 8,789,399 $715,910,314 +$32,118,674 $82.33 92
2014 Q1 8,321,792 $638,198,251 +$51,685,578 $76.69 81
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .